Charles Remsberg left his post as CEO of Hocoma U.S.A for a similar position with a California-based bionic technologies company.
Remsberg will become CEO of Tibion Corp. of Moffett Field, Calif. The company has developed a bionic leg device that helps rehabilitate patients with neuromuscular impairment from stroke or chronic disease. The device, which looks similar to a knee brace, is in limited sales and clinical trials in the U.S., but Tibion is looking to scale up global marketing next year.